Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
収録刊行物
-
- The Lancet Neurology
-
The Lancet Neurology 17 (12), 1053-1060, 2018-12
Elsevier BV